T2490 |
Osimertinib
|
1421373-65-0
|
99.83%
|
|
Osimertinib (AZD-9291) is an EGFR third-generation inhibitor that inhibits the T790M resistance mutation produced by second-generation EGFR inhibitors with irrev...
|
T2106 |
WS6
|
1421227-53-3
|
99.83%
|
|
WS6, a β cell proliferation inducer, regulates Erb3 binding protein-1 (EBP1) and the IκB kinase pathway.
|
T6196 |
PP1
|
172889-26-8
|
99.82%
|
|
PP1 (AGL 1872), a specific and effective Src inhibitor, is with IC50 for Lck/Fyn is 5 nM/ 6 nM, respectively.
|
T15621 |
Rilematovir
|
1383450-81-4
|
99.82%
|
|
Rilematovir (JNJ-678) is an inhibitor of fusion protein with antiviral activity and low cytotoxicity. Rilematovir can be used in studies about respiratory syncyt...
|
T2851 |
Daphnetin
|
486-35-1
|
99.82%
|
|
Daphnetin (7,8-Dihydroxycoumarin), a natural coumarin derivative, is a protein kinase inhibitor with inhibitory for EGFR (IC50: 7.67 μM), PKA (IC50: 9.33 μM), an...
|
T2280 |
Endoxifen (Z-isomer)
|
112093-28-4
|
99.81%
|
|
Endoxifen Z-isomer (EDX) is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptors that also inhibits aromatase ac...
|
T7175 |
Alflutinib mesylate
|
2130958-55-1
|
99.81%
|
|
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.
|
T11157L |
EGFR-IN-1 hydrochloride
|
2227455-78-7
|
99.8%
|
|
EGFR-IN-1 hydrochloride is an irreversible and specific inhibitor of L858R/T790M mutant EGFR with 100-fold selectivity over wild-type EGFR. EGFR-IN-1 hydrochlori...
|
T6153 |
Icotinib
|
610798-31-7
|
99.79%
|
|
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.
|
T2307 |
Icotinib Hydrochloride
|
1204313-51-8
|
99.77%
|
|
Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineopla...
|
T79851 |
Labuxtinib
|
1426449-01-5
|
99.77%
|
|
Labutinib is a selective inhibitor of the c-kit tyrosine kinase [1].
|
T3721 |
Avitinib maleate
|
1557268-88-8
|
99.77%
|
|
Avitinib maleate is a pyrrolopyrimidine-based irreversible epidermal growth factor receptor (EGFR) inhibitor.
|
T12542 |
Rilzabrutinib
|
1575596-29-0
|
99.76%
|
|
Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).
|
T4528 |
Tyrphostin AG 528
|
133550-49-9
|
99.74%
|
|
Tyrphostin AG 528 (Tyrphostin B66) is an inhibitor of EGFR (IC50: 4.9 μM) and ErbB2 (IC50: 2.1 μM).
|
T6824 |
EAI045
|
1942114-09-1
|
99.73%
|
|
EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor.
|
T16162 |
Mutated EGFR-IN-1
|
1421372-66-8
|
99.73%
|
|
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant...
|
T2446 |
KI8751
|
228559-41-9
|
99.73%
|
|
KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM.
|
T8151 |
Mobocertinib
|
1847461-43-1
|
99.72%
|
|
Mobocertinib (tak788) is a potent inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent
|
T6235 |
Lapatinib Ditosylate
|
388082-77-7
|
99.71%
|
|
Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).
|
T2995 |
Chrysophanol
|
481-74-3
|
99.7%
|
|
Chrysophanol (Turkey Rhubarb) is an EGFR/mTOR pathway inhibitor, which can be found in rhubarb, and sorrel.
|